NOV Reports Earnings After Four Consecutive Quarters Where Estimates Proved Too Optimistic
NOV Inc. reports first-quarter 2026 earnings after the close on April 27, with analysts expecting $0.17 per share on revenue of approximately $2.07 billion. The central question: can the oilfield equipment and technology provider reverse a troubling pattern of consecutive earnings misses that has seen the company fall short of estimates in each of the past four quarters? With the stock trading above all major moving averages and technical indicators flashing maximum strength buy signals, investors face a critical test of whether operational momentum can finally align with market optimism.
Part 1: Earnings Preview
NOV Inc. is a leading provider of equipment and technology to the oil and gas industry, designing and manufacturing drilling rigs, wellbore technologies, surface equipment, and aftermarket services that support upstream energy operations worldwide. The company's diversified portfolio spans the entire drilling and production lifecycle, making it a key barometer for global energy capital spending trends.
NOV will report Q1 2026 results after the market close on April 27, with the consensus calling for $0.17 per share and revenue of approximately $2.07 billion. The company most recently reported $0.02 per share for Q4 2025, a significant miss that underscored ongoing margin pressures. Compared to the $0.19 reported in Q1 2025, the current estimate implies a 10.5% year-over-year decline, reflecting cautious expectations as the energy sector navigates a period of moderated activity.
Three key themes define this earnings story:
1. Breaking the Miss Streak: NOV has disappointed investors in four consecutive quarters, with misses ranging from 3% to 92%. The Q4 2025 shortfall was particularly severe, with actual EPS of $0.02 falling 92% below the $0.25 estimate. Analysts are watching closely to see if operational improvements and cost discipline can finally deliver results that meet or exceed expectations, restoring credibility with the investment community.
2. International Market Resilience: While North American drilling activity has softened, international markets—particularly in the Middle East and offshore segments—continue to show strength. NOV's exposure to these higher-margin international projects could provide a buffer against domestic weakness, and investors will scrutinize geographic revenue mix and commentary on the international backlog for signs of sustained momentum.
3. Margin Recovery and Operational Efficiency: After reporting a razor-thin 1.66% net margin in the most recent quarter, the market is focused on whether NOV can demonstrate meaningful margin expansion. Management's ability to execute on cost reduction initiatives, improve manufacturing efficiency, and optimize the product mix will be critical to demonstrating that the business can generate acceptable returns even in a more challenging activity environment.
Ahead of the release, analyst sentiment has deteriorated slightly, with the average recommendation slipping from 3.47 to 3.42 over the past month. The consensus price target of $20.89 sits just above the current trading level, suggesting limited upside is priced in. Several analysts have noted concerns about near-term visibility and the sustainability of international strength, while others point to NOV's diversified portfolio and aftermarket services as potential stabilizers if new equipment demand softens further.
Part 2: Historical Earnings Performance
NOV's recent earnings track record reveals a company struggling to meet expectations with concerning consistency. Over the past four quarters, the company has missed estimates every single time, with surprises ranging from a modest 3.3% shortfall in Q2 2025 to a dramatic 92% miss in the most recent Q4 2025 report.
The pattern shows deteriorating performance through 2025. After missing by 24% in Q1 2025 ($0.19 actual vs. $0.25 estimate), NOV briefly stabilized with a near-miss in Q2 (off by just 3.3%). However, the second half of the year brought accelerating disappointments: a 54% miss in Q3 2025 and then the severe 92% shortfall in Q4, when the company reported just $0.02 against a $0.25 consensus.
This consistent underperformance has likely eroded investor confidence and may explain why analysts have become more cautious in their forward estimates. The upcoming Q1 2026 report represents a critical opportunity for management to demonstrate that operational challenges are being addressed and that the business can return to a trajectory of meeting or exceeding market expectations.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Mar 2025 | $0.25 | $0.19 | -24.00% | Miss |
| Jun 2025 | $0.30 | $0.29 | -3.33% | Miss |
| Sep 2025 | $0.24 | $0.11 | -54.17% | Miss |
| Dec 2025 | $0.25 | $0.02 | -92.00% | Miss |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
NOV typically reports earnings after the market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-02-04 | +$0.61 (+3.25%) | $0.56 (2.98%) | -$1.14 (-5.88%) | $1.19 (6.14%) |
| 2025-10-27 | +$0.11 (+0.79%) | $0.32 (2.30%) | +$1.00 (+7.17%) | $0.66 (4.77%) |
| 2025-07-28 | +$0.19 (+1.36%) | $0.23 (1.65%) | -$1.13 (-7.98%) | $0.69 (4.84%) |
| 2025-04-28 | -$0.09 (-0.73%) | $0.29 (2.31%) | -$0.24 (-1.96%) | $1.19 (9.72%) |
| 2025-02-04 | +$0.29 (+2.03%) | $0.66 (4.62%) | +$1.85 (+12.69%) | $1.44 (9.84%) |
| 2024-10-24 | -$0.02 (-0.13%) | $0.42 (2.72%) | +$0.46 (+3.01%) | $0.85 (5.57%) |
| 2024-07-25 | +$0.42 (+2.30%) | $0.82 (4.49%) | +$1.18 (+6.32%) | $1.79 (9.59%) |
| 2024-04-25 | +$0.12 (+0.64%) | $0.41 (2.20%) | -$0.08 (-0.42%) | $1.56 (8.23%) |
| Avg Abs Move | 1.40% | 2.91% | 5.68% | 7.34% |
Historical price behavior around NOV earnings shows significant volatility, with Day +1 moves averaging 5.68% in absolute terms—well above typical single-day ranges for the stock. The direction of these moves has been mixed but often dramatic, with the most recent Q4 2025 report triggering a 5.88% decline the day after release, consistent with the severe earnings miss.
Looking across the past eight quarters, Day +1 reactions have ranged from a 12.69% surge (February 2025) to a 7.98% drop (July 2025), underscoring how sensitive the stock is to earnings results and guidance. The average Day +1 range of 7.34% suggests investors should prepare for substantial price movement regardless of direction. Day 0 moves have been more muted, averaging just 1.40%, which aligns with the after-close reporting schedule where most price discovery occurs in the following session.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 05/15/26 (DTE 21) |
| Expected Move | $1.57 (7.67%) |
| Expected Range | $18.93 to $22.07 |
| Implied Volatility | 46.76% |
The options market is pricing an expected move of 7.67% for the May 15 expiration, which aligns closely with the 7.34% average Day +1 range observed in recent earnings reports. This suggests options traders are anticipating volatility consistent with NOV's historical post-earnings behavior, neither unusually conservative nor aggressive in their positioning.
Part 3: What Analysts Are Saying
Analyst sentiment on NOV currently sits at 3.42 on the five-point scale, placing the stock in Hold territory with a slight bullish tilt. The consensus has deteriorated over the past month, slipping from 3.47 as the string of earnings misses has prompted reassessment. The average price target of $20.89 implies just 1.9% upside from the current $20.50 level, suggesting analysts see limited near-term appreciation potential.
The rating breakdown shows a divided Street: 4 Strong Buys and 2 Moderate Buys are offset by 12 Hold ratings, 0 Moderate Sells, and 1 Strong Sell. This distribution reflects uncertainty about the company's ability to inflect positively, with the majority of analysts adopting a wait-and-see posture. The shift from last month—when there were 3 Moderate Buys versus 2 currently—indicates some analysts have downgraded their stance following the disappointing Q4 results.
Price target estimates range from a low of $18.00 to a high of $23.00, a relatively tight band that suggests analysts have converging views on valuation despite their differing ratings. The modest 1.9% implied upside to the mean target indicates the market has largely priced in the consensus view, leaving limited room for appreciation unless the company can deliver a meaningful positive surprise that shifts expectations higher.
Part 4: Technical Picture
NOV enters earnings with strong technical momentum, as the Barchart Technical Opinion currently registers an 88% Buy signal, up sharply from 48% just one week ago. This dramatic strengthening reflects improving price action and positive indicator readings across multiple timeframes. The signal has held steady at 88% over the past month, suggesting the recent surge represents a sustained shift rather than a brief spike.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal indicates near-term momentum is positive but not at extreme levels, leaving room for further upside if earnings catalyze additional buying
- Medium-term (100% Buy): Maximum buy signal across the intermediate timeframe reflects strong trend alignment and suggests the stock has established a solid foundation for continued strength
- Long-term (100% Buy): Maximum buy signal in the longer-term view indicates the broader trend structure remains firmly bullish, with the stock well-positioned above key support levels
Trend Characteristics: The technical environment shows Maximum strength and is Strengthening, indicating powerful momentum heading into the earnings release with indicators aligned across all timeframes.
The stock is trading at $20.50, positioned above all major moving averages: the 5-day ($19.84), 10-day ($19.52), 20-day ($19.33), 50-day ($19.34), 100-day ($18.25), and 200-day ($15.86).
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $19.84 | 50-Day MA | $19.34 |
| 10-Day MA | $19.52 | 100-Day MA | $18.25 |
| 20-Day MA | $19.33 | 200-Day MA | $15.86 |
This clean technical setup—with price above every meaningful moving average and maximum buy signals across timeframes—suggests the market has been anticipating positive developments. However, this also means expectations are elevated heading into the report, and any disappointment could trigger sharp profit-taking given the stock's 29% rally from the 200-day moving average. The 50-day average at $19.34 represents the first meaningful support level, while a break above $21 would likely target the $23 analyst high estimate. The technical picture is supportive, but the burden is on management to deliver results that justify the recent optimism.